NO780366L - Immunoundertrykkende midler og fremgangsmaate ved fremstilling av disse - Google Patents
Immunoundertrykkende midler og fremgangsmaate ved fremstilling av disseInfo
- Publication number
- NO780366L NO780366L NO780366A NO780366A NO780366L NO 780366 L NO780366 L NO 780366L NO 780366 A NO780366 A NO 780366A NO 780366 A NO780366 A NO 780366A NO 780366 L NO780366 L NO 780366L
- Authority
- NO
- Norway
- Prior art keywords
- procedures
- preparation
- immuno suppressants
- suppressants
- immuno
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S524/90—Antigen-antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/764,586 US4191668A (en) | 1977-02-03 | 1977-02-03 | Induction of immunological tolerance |
Publications (3)
Publication Number | Publication Date |
---|---|
NO780366L true NO780366L (no) | 1978-08-04 |
NO153419B NO153419B (no) | 1985-12-09 |
NO153419C NO153419C (no) | 1986-03-19 |
Family
ID=25071153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO780366A NO153419C (no) | 1977-02-03 | 1978-02-02 | Fremgangsmaate for fremstilling av et terapeutisk immunoundertrykkende middel, omfattende et konjugat av d-glutaminsyre: d-lysin-copolymer og et antingen som er et allergen. |
Country Status (17)
Country | Link |
---|---|
US (1) | US4191668A (no) |
JP (1) | JPS53121943A (no) |
AU (1) | AU515181B2 (no) |
BE (1) | BE863656A (no) |
CA (1) | CA1118347A (no) |
CH (1) | CH644521A5 (no) |
DE (1) | DE2804457C2 (no) |
DK (1) | DK155174C (no) |
FI (1) | FI780312A (no) |
FR (1) | FR2379287A1 (no) |
GB (1) | GB1599454A (no) |
LU (1) | LU78997A1 (no) |
MX (1) | MX6266E (no) |
NL (1) | NL7801220A (no) |
NO (1) | NO153419C (no) |
SE (1) | SE464616B (no) |
ZA (1) | ZA78613B (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4276206A (en) * | 1979-01-18 | 1981-06-30 | Scripps Clinic & Research Foundation | Immunochemical conjugates: method and composition |
US4220565A (en) * | 1979-01-18 | 1980-09-02 | Scripps Clinic & Research Foundation | Immunochemical conjugates: method and composition |
US4253995A (en) * | 1980-02-11 | 1981-03-03 | Scripps Clinic And Research Foundation | Immunochemical conjugates: method and composition |
US4253996A (en) * | 1980-02-13 | 1981-03-03 | Scripps Clinic And Research Foundation | Immunochemical conjugates: method and composition |
DE3114362C2 (de) * | 1980-04-11 | 1983-08-18 | Toshiyuki Prof. Nara Hamaoka | Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung |
EP0077158A1 (en) * | 1981-10-09 | 1983-04-20 | Beecham Group Plc | Modified allergens |
US6022544A (en) * | 1983-01-24 | 2000-02-08 | The John Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US5126131A (en) * | 1983-01-24 | 1992-06-30 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates. |
US5370871A (en) * | 1983-01-24 | 1994-12-06 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US4950713A (en) * | 1986-05-30 | 1990-08-21 | La Jolla Pharmaceutical Company | Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals |
US4950469A (en) * | 1986-05-30 | 1990-08-21 | La Jolla Pharmaceutical Company | D-GL conjugate therapy |
US5017648A (en) * | 1986-05-30 | 1991-05-21 | La Jolla Pharmaceutical Company | D-GL conjugate therapy |
CA1309558C (en) * | 1986-05-30 | 1992-10-27 | Quidel | D-gl conjugate therapy |
US5391785A (en) * | 1990-01-16 | 1995-02-21 | La Jolla Pharmaceutial Company | Intermediates for providing functional groups on the 5' end of oligonucleotides |
US5162515A (en) * | 1990-01-16 | 1992-11-10 | La Jolla Pharmaceutical Company | Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
US5268454A (en) * | 1991-02-08 | 1993-12-07 | La Jolla Pharmaceutical Company | Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier |
US5552391A (en) * | 1990-01-16 | 1996-09-03 | La Jolla Pharmaceutical Company | Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
JP2899111B2 (ja) * | 1991-07-15 | 1999-06-02 | ラ ホヤ ファーマシューティカル カンパニー | オリゴヌクレオチドの5’末端へ官能基を提供するための修飾された亜リン酸中間体 |
KR100361933B1 (ko) * | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트 |
US8071737B2 (en) | 1995-05-04 | 2011-12-06 | Glead Sciences, Inc. | Nucleic acid ligand complexes |
US5874409A (en) | 1995-06-07 | 1999-02-23 | La Jolla Pharmaceutical Company | APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
US6410775B1 (en) * | 1995-06-07 | 2002-06-25 | La Jolla Pharmaceutical Company | APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
US6858210B1 (en) | 1998-06-09 | 2005-02-22 | La Jolla Pharmaceutical Co. | Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same |
US6399578B1 (en) | 1998-12-09 | 2002-06-04 | La Jolla Pharmaceutical Company | Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same |
US6458953B1 (en) * | 1998-12-09 | 2002-10-01 | La Jolla Pharmaceutical Company | Valency platform molecules comprising carbamate linkages |
US7084256B2 (en) * | 1999-09-24 | 2006-08-01 | Large Scale Biology Corporation | Self antigen vaccines for treating B cell lymphomas and other cancers |
US20030044420A1 (en) * | 1999-09-24 | 2003-03-06 | Mccormick Alison A. | Self antigen vaccines for treating B cell lymphomas and other cancers |
CN1434726A (zh) | 2000-06-08 | 2003-08-06 | 拉卓拉药物公司 | 包含高分子量聚环氧乙烷的多价平台分子 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1282163A (en) * | 1969-08-06 | 1972-07-19 | Beecham Group Ltd | Modified allergens and a process for their preparation |
US3825525A (en) * | 1969-08-06 | 1974-07-23 | Beecham Group Ltd | Allergens reacted with carbodiimides |
-
1977
- 1977-02-03 US US05/764,586 patent/US4191668A/en not_active Expired - Lifetime
-
1978
- 1978-01-31 FI FI780312A patent/FI780312A/fi not_active Application Discontinuation
- 1978-01-31 CA CA000295952A patent/CA1118347A/en not_active Expired
- 1978-02-01 ZA ZA00780613A patent/ZA78613B/xx unknown
- 1978-02-02 SE SE7801268A patent/SE464616B/xx unknown
- 1978-02-02 GB GB4310/78A patent/GB1599454A/en not_active Expired
- 1978-02-02 DE DE2804457A patent/DE2804457C2/de not_active Expired
- 1978-02-02 NL NL7801220A patent/NL7801220A/xx not_active Application Discontinuation
- 1978-02-02 JP JP1105378A patent/JPS53121943A/ja active Granted
- 1978-02-02 NO NO780366A patent/NO153419C/no unknown
- 1978-02-02 DK DK049178A patent/DK155174C/da not_active IP Right Cessation
- 1978-02-03 MX MX786822U patent/MX6266E/es unknown
- 1978-02-03 CH CH124078A patent/CH644521A5/de not_active IP Right Cessation
- 1978-02-03 LU LU78997A patent/LU78997A1/xx unknown
- 1978-02-03 FR FR7803063A patent/FR2379287A1/fr active Granted
- 1978-02-03 BE BE184908A patent/BE863656A/xx not_active IP Right Cessation
- 1978-02-05 AU AU32933/78A patent/AU515181B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
LU78997A1 (fr) | 1978-06-21 |
JPH0428689B2 (no) | 1992-05-15 |
FR2379287A1 (fr) | 1978-09-01 |
NO153419C (no) | 1986-03-19 |
DE2804457C2 (de) | 1984-04-12 |
US4191668A (en) | 1980-03-04 |
FR2379287B1 (no) | 1980-08-29 |
DE2804457A1 (de) | 1978-08-10 |
BE863656A (fr) | 1978-05-29 |
AU515181B2 (en) | 1981-03-19 |
SE7801268L (sv) | 1978-08-04 |
DK155174C (da) | 1989-07-10 |
AU3293378A (en) | 1979-08-09 |
GB1599454A (en) | 1981-10-07 |
JPS53121943A (en) | 1978-10-24 |
SE464616B (sv) | 1991-05-27 |
MX6266E (es) | 1985-02-27 |
CH644521A5 (de) | 1984-08-15 |
DK155174B (da) | 1989-02-27 |
FI780312A (fi) | 1978-08-04 |
DK49178A (da) | 1978-08-04 |
NL7801220A (nl) | 1978-08-07 |
ZA78613B (en) | 1978-12-27 |
CA1118347A (en) | 1982-02-16 |
NO153419B (no) | 1985-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO780366L (no) | Immunoundertrykkende midler og fremgangsmaate ved fremstilling av disse | |
DK353378A (da) | Fremgangsmaade til fr&mstilling af phosphonoacylproliner og dermed beslagtede forbindelser | |
DK3880A (da) | Fremgangsmaade til fremstilling af peptidylargininaldehydderivater og disses anvendelse | |
NO803330L (no) | Elektrolysoer og fremgangsmaate for elektrolysering | |
NO782813L (no) | Nye nitroimidazoler og fremgangsmaate ved fremstilling av disse | |
DK173778A (da) | Fremgangsmaade til fremstilling af mercaptoalkylsulfonylprolinderivater og dermed beslaegtede forbindelser | |
NO782025L (no) | Kunstig nyre og fremgangsmaate for fremstilling av denne | |
NO150879C (no) | Fremgangsmaate for fremstilling av d-camforat av l-carnitinamid og d-camforat av d-carnitinamid | |
DK132779A (da) | Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner | |
DK59778A (da) | Fremgangsmaade til fremstilling af antigen og antistof | |
DK180878A (da) | Fremgangsmaade til fremstilling af imidazoaziner og imidazodiaziner | |
NO791081L (no) | Cementkomposisjoner og fremgangsmaate for fremstilling av disse | |
NO148977C (no) | Froebaerer og fremgangsmaate for fremstilling av denne | |
NO810009L (no) | Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks og anvendelse derav | |
DK431879A (da) | Fremgangsmaade til fremstilling af praeparater og konbinationer indeholdende adenosinderivater | |
DK148828C (da) | Fremgangsmaade til fremstilling af polysaccharider med antigen og immunostimulerende virkning | |
DK113079A (da) | Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf | |
NO783487L (no) | Bindemiddel og fremgangsmaate til fremstilling av samme | |
DK313878A (da) | Indolderivater og fremgangsmaade til fremstilling deraf | |
DK103178A (da) | Azo-forbindelser og fremgangsmaade til fremstilling af disse | |
DK249179A (da) | Fremgangsmaade til fremstilling af 10-deazaaminopterin og dermed beslaegtede forbindelser | |
DK267078A (da) | Fremgangsmaade til fremstilling af n1-glucofuranosid-6-yl-n3-n3-nitrosourinstoffer og derivater deraf | |
DK564777A (da) | Antitumorglykosider og fremgangsmaade til fremstilling af disse | |
NO783479L (no) | Fremgangsmaate ved fremstilling av alkyltiosulfater og alkylidentiosulfater | |
NO791349L (no) | Fenoksyalkyl-trialkoksysilaner og fremgangsmaate til fremstilling av disse |